Encyclopaedia

Explore comprehensive, evidence-informed explanations of key health economics concepts, including their development, application and relationships to other concepts. Published entries are validated through human expert review.

15 concepts

Annuity Payment

A reimbursement structure paying a treatment's total cost to the manufacturer in a series of instalments over time, rather than as a single upfront sum.

PharmacoeconomicsExpert Verified2 related concepts

Clinical Benefit Rate

A cancer outcome measure combining complete response, partial response, and stable disease rates, giving a broader benefit picture than response rate alone.

PharmacoeconomicsExpert Verified2 related concepts

Disease Control Rate

A cancer outcome measure combining complete response, partial response, and stable disease rates, characterising the proportion whose disease did not progress.

PharmacoeconomicsExpert Verified2 related concepts

Dose Response

The relationship between the amount of a drug given and the magnitude of its resulting biological or clinical effect.

PharmacoeconomicsExpert Verified2 related concepts

Half-Life

The time required for a drug's concentration in the body to fall by half, a key parameter determining dosing frequency.

PharmacoeconomicsExpert Verified2 related concepts

Herd Immunity Threshold

The proportion of a population that must be immune to achieve herd immunity, mathematically related to a pathogen's basic reproduction number.

PharmacoeconomicsExpert Verified2 related concepts

Objective Response Rate

The proportion of patients whose tumour shrinks by a predefined amount or disappears entirely following treatment, measured using standardised radiological criteria.

PharmacoeconomicsExpert Verified2 related concepts

Overall Survival

A time-to-event measure defined as the time from treatment start, or trial randomisation, until death from any cause.

PharmacoeconomicsExpert Verified2 related concepts

Pharmacokinetics

The study of how the body absorbs, distributes, metabolises, and eliminates a drug over time, covering bioavailability, clearance, and half-life.

PharmacoeconomicsExpert Verified2 related concepts

Progression-Free Survival

A time-to-event measure defined as the time from treatment start until either disease progression or death from any cause, whichever occurs first.

PharmacoeconomicsExpert Verified2 related concepts

Relative Dose Intensity

A measure comparing the dose intensity a patient actually received to the originally planned, full dose intensity, expressed as a percentage.

PharmacoeconomicsExpert Verified2 related concepts

Steady State

A pharmacokinetic condition where a drug's concentration remains stable because the rate of administration equals the rate of elimination.

PharmacoeconomicsExpert Verified2 related concepts

Therapeutic Index

A drug's safety margin, calculated as the ratio between the dose that produces toxicity and the dose producing the desired effect.

PharmacoeconomicsExpert Verified2 related concepts

Vaccine Effectiveness

The degree to which a vaccine reduces disease risk under real-world conditions in a general population, unlike efficacy measured under trial conditions.

PharmacoeconomicsExpert Verified2 related concepts

Vaccine Efficacy

The degree to which a vaccine reduces disease risk among vaccinated individuals under the controlled conditions of a clinical trial.

PharmacoeconomicsExpert Verified2 related concepts